Knowledge Distillery

Filter the news according their assigned tags.
| Meta-analysis Systematic Review  

Cognitive impairment can be caused by infections with various pathogens, including SARS-CoV-2. Research has yet to determine the true incidence and…

more...
| Observational study: prospective longitudinal cohort  

Infections, including infection with SARS-CoV-2 (COVID-19), could alter the course of multiple sclerosis (MS). Previous studies assessing the effects…

more...
| Cross-sectional case-control studies  

Persistent symptoms after COVID-19 constitute the long COVID syndrome, also called post-acute sequelae of SARS-CoV-2 infection (PASC). COVID-19…

more...
| Cross-sectional case-control studies  

There are concerns for safety regarding SARS-CoV-2 vaccines for patients with autoimmune neuromuscular disease. In this substudy of a prospective…

more...
| Literature Review  

This review explores the neuroinflammatory pathways underlying COVID-19-induced central nervous system (CNS) injury, with a focus on mechanisms of…

more...
| Literature Review  

SARS-CoV-2 had a significant and lasting negative impact on the health and economies of millions of individuals all over the globe. At the level of…

more...
| Meta-analysis Systematic Review  

This study systematically reviews the available evidence on resting-state functional magnetic resonance imaging (rs-fMRI) related to neurological…

more...
| Cross-sectional case-control studies  

Demyelinating diseases including multiple sclerosis are associated with prior infectious exposures. In this article the authors assessed whether…

more...
| Observational study: prospective longitudinal cohort  

Ninety-six patients with severe COVID-19 who survived intensive care unit (ICU) admission were enrolled in this prospective longitudinal cohort study.…

more...
| Cross-sectional case-control studies  

Post-mortem studies have shown that patients dying from SARS-CoV-2 infection frequently have pathological changes in their CNS, particularly in the…

more...
| Cross-sectional case-control studies  

Messenger RNA (mRNA) vaccines provide robust protection against SARS-CoV-2 in healthy individuals. However, immunity after vaccination of patients…

more...
| Cross-sectional case-control studies  

The COVID-19 pandemic raised concern amongst clinicians that disease-modifying therapies (DMT), particularly anti-CD20 monoclonal antibodies (mAb) and…

more...